Kendall Forbes
CIK: 0002038507
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Guardian Pharmacy Services, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 27, 2026GRDN
Guardian Pharmacy Services, Inc.
Exercise(M)Direct608.6K shares- - Mar 20, 2026GRDN
Guardian Pharmacy Services, Inc.
Sale(S)Direct346.7K shares at avg. $29.68$10.3M - Mar 1, 2026GRDN
Guardian Pharmacy Services, Inc.
Award(A)Direct9K shares- - Feb 11, 2026GRDN
Guardian Pharmacy Services, Inc.
Award(A)DirectStock Option (right to buy)
50K shares- - Dec 4, 2025GRDN
Guardian Pharmacy Services, Inc.
Gift(G)Direct21.5K shares- - Sep 27, 2025GRDN
Guardian Pharmacy Services, Inc.
Exercise(M)Direct608.6K shares- - May 28, 2025GRDN
Guardian Pharmacy Services, Inc.
Sale(S)Direct65K shares at avg. $20.16$1.3M - May 27, 2025GRDN
Guardian Pharmacy Services, Inc.
Sale(S)Direct350.1K shares at avg. $20.16$7.1M - Mar 28, 2025GRDN
Guardian Pharmacy Services, Inc.
Exercise(M)Direct608.6K shares- - Feb 5, 2025GRDN
Guardian Pharmacy Services, Inc.
Award(A)Direct10.4K shares- - Sep 27, 2024GRDN
Guardian Pharmacy Services, Inc.
Award(A)DirectClass B Common Stock
2.4M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 27, 2026 | GRDN Guardian Pharmacy Services, Inc. | Exercise(M) | 608,570 | - | $0 | Direct |
| Mar 20, 2026 | GRDN Guardian Pharmacy Services, Inc. | Sale(S) | 346,672 | $29.68 | $10,290,092 | Direct |
| Mar 1, 2026 | GRDN Guardian Pharmacy Services, Inc. | Award(A) | 8,952 | - | $0 | Direct |
| Feb 11, 2026 | GRDN Guardian Pharmacy Services, Inc. | Award(A) Stock Option (right to buy) | 50,000 | - | - | Direct |
| Dec 4, 2025 | GRDN Guardian Pharmacy Services, Inc. | Gift(G) | 21,500 | - | - | Direct |
| Sep 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | Exercise(M) | 608,570 | - | - | Direct |
| May 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | Sale(S) | 64,991 | $20.16 | $1,310,219 | Direct |
| May 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | Sale(S) | 350,058 | $20.16 | $7,057,169 | Direct |
| Mar 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | Exercise(M) | 608,570 | - | - | Direct |
| Feb 5, 2025 | GRDN Guardian Pharmacy Services, Inc. | Award(A) | 10,385 | - | - | Direct |
| Sep 27, 2024 | GRDN Guardian Pharmacy Services, Inc. | Award(A) Class B Common Stock | 2,434,280 | - | - | Direct |
1-11 of 11 transactions
About Forbes Kendall
Forbes Kendall (SEC CIK 0002038507) files insider reports with the SEC as Guardian Pharmacy Services, Inc. (GRDN).
Signal8 holds 11 ownership filings by Forbes Kendall (1 Form 3, 10 Form 4), filed between Sep 25, 2024 and Sep 28, 2026. Those filings report 11 transactions, from Sep 27, 2024 to Sep 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Forbes Kendall's filings is in ATLANTA, GA.
Recent filings by Forbes Kendall
- Sep 27, 2026: Option exercise of GRDN shares (Form 4, code M).
- Mar 20, 2026: Open-market sale of GRDN shares (Form 4, code S).
- Mar 1, 2026: Grant or award of GRDN shares (Form 4, code A).
- Feb 11, 2026: Grant or award of GRDN derivative securities (Form 4, code A).
- Dec 4, 2025: Gift of GRDN shares (Form 4, code G).
Other insiders filing for Guardian Pharmacy Services, Inc. (GRDN)
- Mudd William Franklin
- Weir Robert
- Ackerman John, Director
- Salentine Thomas J Jr, Director
- Martin David Norman
- Pharmacy Investors, LLC, Officer